Health and Wellness Editor
Composed of three monoclonal antibodies, Immunome’s IMM-BCP-01 has demonstrated strong performance in preclinical testing.
The Comcast RISE program is focused on helping Philly-area small businesses hit hardest by the pandemic with free advertising, technology upgrades, and grants.
Run by Jefferson Health and SEAMAAC, the Hansjörg Wyss Wellness Center offers clinical care and social services to patients, regardless of their citizenship or health insurance status.
Researchers modeled how the pandemic could have played out very differently in Philadelphia had evictions not been banned.
The money will be used to expand Stix’s product line as well as grow their digital education platform.
Immunotherapy trailblazer Carl June received the 2020 Sanford Lorraine Cross Award just months after being named a Dan David Prize Laureate.
NextUp: The Radnor-Based Biopharma Company Developing a Hormone-Targeting Treatment for Hypertension
Mineralys Therapeutics just completed a $40 million Series A funding round, which will allow them to take their lead drug candidate MLS-101 into a Phase II proof-of-concept study.
Here’s how Penn Medicine, Trinity Health, and community faith leaders collaborated on “operationalizing equity” around COVID-19 vaccine distribution.
Strella Biotechnology monitors an increase in ethylene production in fruit, signaling when produce needs to get to consumers before spoiling.
The FDA-cleared Lia pregnancy test is discreet, eco-friendly, and 99 percent accurate.
Precision medicine company Coriell Life Sciences is working to tailor treatment plans based on patients’ unique genetic makeups.
The Cancer Epigenetics Institute aims to increase therapy options for cancer patients and to promote educational opportunities for students and faculty.
The grant will allow for a more than 40,000-square-foot addition to their biopharmaceutical and biologics education and training center.
BioLattice is currently working on a prototype made from biologics and synthetic polymers.
The test is designed to work with existing RT-PCR instruments, meaning folks can now be screened for novel variants in addition to the original coronavirus.